P2Y12 Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model

P2Y12 Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model

Current guidelines recommend initiation of a P2Y12 inhibitor for all patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) at the time of diagnosis (pre-treatment); however, there are no randomized trials directly comparing pre-treatment with initiation at the time of angiography to supp...

Full description

Bibliographic Details
Main Authors: James Gunton, Trent Hartshorne, Jeremy Langrish, Anthony Chuang, Derek Chew
Format: Article
Language:English
Published: MDPI AG 2016-08-01
Series:Journal of Clinical Medicine
Subjects:
non-ST segment myocardial infarction
percutaneous coronary intervention
cardiac catheterization and angiography
Online Access:http://www.mdpi.com/2077-0383/5/8/72

Similar Items

Similar Items